Skip to main content
. 2019 Dec 26;6(3):437–439. doi: 10.1001/jamaoncol.2019.5566

Table. Differences in Baseline and Worst Postbaseline Symptom Rates Between Patient and Clinician Reports.

Symptom Baseline, % Worst Postbaseline, %
PRO CTCAE % Difference P Value PRO CTCAE % Difference P Value
Agitation 62.6 13.9 48.7 <.001 61.0 29.3 31.7 <.001
Anorexia 75.0 44.8 30.2 <.001 83.6 100 –16.4 <.001
Anxiety 58.4 25.9 32.5 <.001 73.6 28.2 45.4 <.001
Cognitive disturbance 45.1 5.1 40.0 <.001 70.7 26.0 44.7 <.001
Constipation 36.6 12.0 24.6 <.001 68.5 33.7 34.8 <.001
Cough 92.9 38.1 54.8 <.001 75.0 100 –25.0 <.001
Dermatitis 4.2 1.2 3.0 .059 65.3 81.4 –16.1 <.001
Diarrhea 64.0 4.0 60.0 <.001 77.8 100 –22.2 <.001
Diplopia 8.5 0.6 7.9 <.001 39.8 3.3 36.5 <.001
Dizziness 35.1 15.1 20.0 <.001 59.9 31.2 28.7 <.001
Dyspnea 26.2 23.4 2.8 .45 46.9 60.8 –13.9 .002
Edema 19.6 7.9 11.7 <.001 43.4 32.7 10.7 <.001
Fatigue 93.3 43.1 50.2 <.001 98.9 96.7 2.2 .10
Headache 50.2 21.1 29.1 <.001 64.9 42.8 22.1 <.001
Hypopigmentation 3.6 1.2 2.4 .157 69.5 9.0 60.5 <.001
Insomnia 58.0 37.0 21.0 <.001 78.5 68.4 10.1 .02
Nausea 45.7 22.4 23.3 <.001 69.1 49.9 19.2 <.001
Pain
Abdominal 31.1 15.0 16.1 <.001 43.5 28.8 14.7 <.001
Bone 61.5 7.7 53.8 <.001 66.7 54.9 11.8 .05
Burning 21.1 0.6 20.5 <.001 86.2 46.1 40.1 <.001
Myalgia 54.0 20.0 34.0 <.001 66.0 54.7 11.3 .18
Pruritus 42.8 3.0 39.8 <.001 88.6 73.1 15.5 <.001
Vision (blurred) 8.5 4.5 4.0 .11 39.8 18.8 21.0 <.001
Vomiting 29.5 13.6 15.9 <.001 37.8 26.6 11.2 <.001

Abbreviations: CTCAE, Common Terminology Criteria for Adverse Events; PRO, patient-reported outcome.